Bristol-Myers Squibb: Amylin Pharmaceuticals, LLC
 
Amylin Pharmaceuticals, LLC9625 Towne Centre Drive
San Diego, CA 92121
858-552-2200
History
Amylin Pharmaceuticals History

Amylin Pharmaceuticals, LLC was founded in 1987 on the strength of a conviction that a new peptide hormone discovered at Oxford University, called amylin, could have real therapeutic value for patients. That belief gave birth to a process of continual discovery and innovation that has defined Amylin for a quarter of a century, allowing it to bring three innovative medicines to patients with diabetes. Now as a wholly-owned subsidiary of Bristol-Myers Squibb, Amylin remains committed to the discovery of innovative medicines that have the potential to transform the way diabetes and related metabolic disorders are treated.

Summary of Key Activities

Amylin is a well-established biopharmaceutical company with advanced capabilities in research, development, manufacturing, and all aspects of commercialization.

Research. Amylin continues to explore the potential of peptide science with a peptide hybrid (fusion of two different peptide hormones, within a single molecular entity with dual pharmacology) that is moving to clinical development for the potential treatment of diabetes.

Development. Amylin continues to expand opportunities for its commercialized products and focus on innovative new therapies for diabetes and metabolic disease. Amylin’s experienced clinical development organization is focused on the following areas: the development of exenatide suspension formulations that do not need reconstitution; and metreleptin, a recombinant analog of the human hormone leptin for the treatment of rare forms of lipodystrophy, which is currently under regulatory review and, if approved, would represent the first and only treatment option to target the underlying pathophysiology of this rare and life-threatening disease.

Key Activities
Amylin Ohio, LLC Manufacturing. Amylin has a state-of-the-art sterile production facility in West Chester, Ohio, which manufactures the global supply of BYDUREON (exenatide extended-release for injectable suspension). The facility employs baccalaureate level scientists and engineers in areas such as analytical chemistry, microbiology, manufacturing engineering, and other related disciplines.

Ohio Address:
Amylin Ohio, LLC
8814 Trade Port Drive
West Chester, OH 45071-8726
(513) 645-2600

Challenging science and changing lives—these are the guiding principles at Amylin, where extraordinarily dedicated men and women are working to improve the lives of millions of people impacted by diabetes and other metabolic diseases.

Amylin values talent, commitment, passion, and diversity in employees and promotes a collaborative culture that embraces creativity, flexibility, and responsiveness. The company encourages employee development and recognizes accomplishments. Amylin provide a collegial environment in which each individual has the opportunity to make important contributions.

Search Amylin Jobs

 
 
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.
You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.